AR126501A1 - NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE - Google Patents
NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINEInfo
- Publication number
- AR126501A1 AR126501A1 ARP220101896A ARP220101896A AR126501A1 AR 126501 A1 AR126501 A1 AR 126501A1 AR P220101896 A ARP220101896 A AR P220101896A AR P220101896 A ARP220101896 A AR P220101896A AR 126501 A1 AR126501 A1 AR 126501A1
- Authority
- AR
- Argentina
- Prior art keywords
- spiropyrrolidine
- formula
- antiviral agents
- pharmaceutically acceptable
- agents derived
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 241000711573 Coronaviridae Species 0.000 abstract 1
- 208000001528 Coronaviridae Infections Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención revela compuestos de fórmula (1), y sales de uso farmacéutico aceptables del mismo: que inhiben la actividad de replicación del coronavirus. La invención se refiere además a composiciones farmacéuticas que comprenden un compuesto de fórmula (1) o una sal de uso farmacéutico aceptable del mismo, y a métodos de tratamiento o prevención de una infección por coronavirus en un sujeto que lo necesita, que comprenden administrar al sujeto una cantidad terapéuticamente efectiva de un compuesto de fórmula (1) o una sal de uso farmacéutico aceptable del mismo.The present invention discloses compounds of formula (1), and pharmaceutically acceptable salts thereof: that inhibit the replication activity of the coronavirus. The invention further relates to pharmaceutical compositions comprising a compound of formula (1) or a pharmaceutically acceptable salt thereof, and to methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula (1) or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063325801P | 2020-03-31 | 2020-03-31 | |
| US202017479455A | 2020-09-20 | 2020-09-20 | |
| US202163225122P | 2021-07-23 | 2021-07-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR126501A1 true AR126501A1 (en) | 2023-10-18 |
Family
ID=88679296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220101896A AR126501A1 (en) | 2020-03-31 | 2022-07-20 | NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR126501A1 (en) |
-
2022
- 2022-07-20 AR ARP220101896A patent/AR126501A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023000167A1 (en) | Functionalized peptides as antiviral agents | |
| UY39529A (en) | NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE | |
| CO2023002852A2 (en) | Functionalized peptides as antiviral agents | |
| MX2023005983A (en) | Novel spiropyrrolidine derived antiviral agents. | |
| MX2024003960A (en) | Nitrile-containing antiviral compounds. | |
| UY26635A1 (en) | SYNERGIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
| EA200702445A1 (en) | THIAZOLE COMPOUNDS AND METHODS OF THEIR APPLICATION | |
| DOP2005000039A (en) | HYDROCHLORIDE OF [4- (5-AMINOMETIL-2-FLUORO-PHENYL) - PIPERIDIN-1-IL] - (4-BOMO-3-METHYL-5-PROPOXI-TIOFEN-2-IL) -METANONE AS AN INHIBITOR OF THE MASTOCYT TRIPTASE | |
| UY39032A (en) | HETEROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS | |
| AR127247A1 (en) | CYCLOPENTYLPYRAZOLE CDK2 INHIBITORS | |
| BR112023022484A2 (en) | COMPOUND IN GENERAL FORMULA (I) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | |
| CO2022014992A2 (en) | Pharmaceutical composition for prevention or treatment of epidemic rna viral infectious disease | |
| CO4130200A1 (en) | HELPFUL HIV PROTEASE INHIBITORS IN AIDS TREATMENT | |
| AR126501A1 (en) | NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE | |
| AR126482A1 (en) | ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE | |
| MA27749A1 (en) | 2- (BUTYL-1-SULFONYLAMINO) -N- [1 (R) - (6-METOXY-PYRIDIN-3-YL) -PROPYL] -BENZAMIDE, USE OF SAID COMPOUND IN THE FORM OF A MEDICINAL PRODUCT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME LEDIT COMPOSE | |
| MX2024001377A (en) | Novel spiropyrrolidine derived antiviral agents. | |
| BR112023002077A2 (en) | COMPOUND AND ITS USE, COMPOSITION AND PHARMACEUTICAL FORMULATION | |
| CL2022001935A1 (en) | Antiviral compounds containing nitrile | |
| GB2619215A (en) | 6-methyluracil derivatives with anticholinesterase activity and their use | |
| AR122280A1 (en) | ANTIVIRAL HETEROCYCLIC COMPOUNDS | |
| AR129003A1 (en) | HETEROCYCLIC ANTIVIRAL COMPOUNDS | |
| AR129423A1 (en) | USEFUL COMPOUNDS IN HIV THERAPY | |
| AR128051A1 (en) | PARP1 INHIBITORS | |
| AR127695A1 (en) | CHROMANO AMIDINE MONOBACTAMIC COMPOUNDS TO TREAT BACTERIAL INFECTIONS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |